Friday, March 3, 2017

Is Biotech Taking It's Medicine?

Despite the heavy political whipping this industry has taken the last few months biotech stocks have quietly been moving up along with the market.  For the first time since September 23, 2016 the IShares Nasdaq Biotechnology Fund(IBB) is trading over $300. I think if the fund can close above the high set in September 2016 we might have a chance it can go on a run that made it an investor favorite for years. The next resistance area looks to be in the $340 range.



Visit StockCharts.com to see more great charts.

No comments :

Post a Comment